NEW YORK (GenomeWeb News) — Oxford Gene Technology, St. George’s University of London, and St. George’s Healthcare NHS plan to develop a single-platform microarray that could “diagnose multiple sexually transmitted [diseases],” OGT said today.

 

OGT said the test would have the capacity to diagnose many STD pathogens in a single specimen and would offer cost-effective results on the same day. It did not elaborate.